Results 101 to 110 of about 54,698 (143)

Tratamiento de mesotelioma pleural maligno con pemetrexed como fármaco de primera línea; experiencia en dos instituciones mexicanas

, 2019
El mesotelioma pleural maligno (MPM) es una neoplasia agresiva y poco frecuente; en este trastorno se produce transformación maligna de las células mesoteliales, que se dividen y crecen sin control; su incidencia se ha incrementado en los últimos 20 años.
Martínez Prieto, M., Rivera Rivera, S., Téllez Trevilla, G., Gómez Villanueva, A., Hernández-Luis, G.N.   +4 more
core  

Outcomes of multicystic peritoneal mesothelioma treatment with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

BJS Open, 2021
Zahid A, Clarke L, Carr N, Chandrakumaran K, Tzivanakis A, Dayal S, Mohamed F, Cecil T, Moran BJ.   +8 more
europepmc   +1 more source

Brief report: attitudes and barriers toward genetic testing in pleural mesothelioma: a nationwide Italian survey. [PDF]

Fam Cancer
Cerbone L, Perrino M, Grosso F, Ganzinelli M, Lo Russo G, Pasello G, Zucali PA, Ceresoli GL, Occhipinti M, Sculco M, on the behalf of MET-I (Mesothelioma team Italy).   +10 more
europepmc   +1 more source

Mesothelioma and Social Security Benefits in Brazil: 2019 to 2021. [PDF]

Rev Bras Med Trab
Gomes LEFE, Souza NSS.
europepmc   +1 more source

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis. [PDF]

J Cancer Res Clin Oncol, 2021
Carosio R, Fontana V, Mastracci L, Ferro P, Grillo F, Banelli B, Canessa PA, Dessanti P, Vigani A, Morabito A, Pfeffer U, Poggi A, Roncella S, Pistillo MP.   +13 more
europepmc   +1 more source

Peritoneal Mesothelioma in a Patient with Long-Standing Crohn's Disease: Cause or Coincidence? [PDF]

GE Port J Gastroenterol
Prata R, Lages Martins P, Borges VP, Botelho P, Figueiredo A, Ramos J.   +5 more
europepmc   +1 more source

Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study. [PDF]

JTCVS Open
Collaud S, Stork T, Adamkova D, Aigner C, Bravio I, Brunello A, Cerbone L, Clermidy H, De Cock L, Gasperoni S, Girard N, Mariuk-Jarema A, Lefering R, Melis E, Marquina G, Mazzeo F, Mykoliuk I, Pantaleo MA, Penel N, Schildhaus HU, Strippoli S, Vincenzi B, Watson S, Blay JY, Bauer S.   +24 more
europepmc   +1 more source

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. [PDF]

Rev Col Bras Cir, 2023
Vallejo JSA, Queiroz FL, Lacerda Filho A, França Neto PR, Costa BXMD, Paiva RA, Garcia SLM, Silva SB.   +7 more
europepmc   +1 more source

Comparison of 3 Randomized Clinical Trials of Frontline Therapies for Malignant Pleural Mesothelioma.

JAMA Netw Open, 2022
Meirson T, Pentimalli F, Cerza F, Baglio G, Gray SG, Correale P, Krstic-Demonacos M, Markel G, Giordano A, Bomze D, Mutti L.   +10 more
europepmc   +1 more source

Solid epithelioid peritoneal mesothelioma with pulmonary metastasis in feline. [PDF]

Braz J Vet Med
de Carvalho HCT, Gundim LF, Pastor FM, Guimarães GH, Coleto AF, Szabó MPJ, Medeiros-Ronchi AA.   +6 more
europepmc   +1 more source